PROSTATAKREBS-BIOMARKER

European patent · EP3617706 · In force

Register entry

Publication number
EP3617706
Application number
EP19185536
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 19, 2014
Published
Mar 4, 2020
Granted
Jun 1, 2022
Protection ends at the latest
Dec 18, 2034
Next annual fee due
Dec 31, 2026
IPC classes
G01N 33/574 (2006.01)
Priority
GB 201322800 20.12.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  3. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  4. Apr 12, 2023

    Change

    Published in Swissreg on 12.04.2023

  5. Jan 1, 2023

    Change

    Published in Swissreg on 01.01.2023

  6. Oct 31, 2022

    Agent removed

    Representative
    Kirker & Cie SA, Conseils en Marques, Rue de Genève 122,, Case Postale 153, 1226 Thônex (removed)

    Published in Swissreg on 31.10.2022

  7. Oct 31, 2022

    Agent entered

    Representative
    Kirker & Cie SA, Rue de Genève 122, CP 153, 1226 Genève-Thônex

    Published in Swissreg on 31.10.2022

  8. Oct 27, 2022

    Agent entered

    Representative
    Kirker & Cie SA, Conseils en Marques, Rue de Genève 122,, Case Postale 153, 1226 Thônex

    Published in Swissreg on 27.10.2022

1 earlier entry
  1. Jun 1, 2022

    Granted

    Published in Swissreg on 01.06.2022

Parties

Inventor

MURPHY, Brendan

Leixlip, Co Kildare, IE

PENNINGTON, Stephen

Whitegate, Co Clare, IE

WATSON, William

Lucan, Co Dublin, IE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.